More tools:Markets·Screener·Research·Chat

Insulet Corporation (PODD) Financial Statements

Insulet Corporation
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SRF439
XNAS · usd
142.02▼ 0.26 (-0.18%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close142.28
Day's Range139.27 – 147.39
52-Week Range126.40 – 354.88
Volume2.2M
Avg Volume1.8M
Share Statistics
Shares Outstanding
Employees5,400
ExchangeXNAS
Listed2007-05-15
Share count as of July 29, 2026
Loading Income Statement…
Key questions about Insulet Corporation (PODD)
What is Insulet Corporation's Market Cap?
Insulet Corporation's Market Cap is $9.8B, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Enterprise Value?
Insulet Corporation's Enterprise Value is $10.3B, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Trailing P/E?
Insulet Corporation's Trailing P/E is 26.2×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Price / Sales?
Insulet Corporation's Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's EV / Revenue?
Insulet Corporation's EV / Revenue is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's EV / EBITDA?
Insulet Corporation's EV / EBITDA is 16.7×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Revenue (TTM)?
Insulet Corporation's Revenue (TTM) is $3.1B, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Net Income (TTM)?
Insulet Corporation's Net Income (TTM) is $375.3M, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's EBITDA?
Insulet Corporation's EBITDA is $615.0M, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Diluted EPS (TTM)?
Insulet Corporation's Diluted EPS (TTM) is 5.41, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+23.5%+33.9%+31.2%+29.9%
Cost of revenue
Gross profit
% of revenue70.2%69.5%72.5%72.2%
Research and development expenses
Selling, general and administrative expenses
Operating income
% of revenue16.2%16.0%18.7%16.7%
Interest expense
Interest income
Loss on extinguishment of debt
Other (expense) income, net
Income before income taxes
Income tax expense
Net income
% of revenue11.8%12.0%13.0%12.4%
Basic (in dollars per share)
Diluted (in dollars per share)